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converted Susceptible mice to 
Unsusceptible mice. Although it 
is unlikely that naturally occurring 
stress responses can be turned off 
in such a potent and simple man-
ner, the paper should encourage a 
new focus of research on the VTA in 
particular and on reward circuits in 
general. Future work on reward cir-
cuits would complement the consid-
erable ongoing efforts on regulation 
of mood and anxiety by circuits of 
the amygdala and prefrontal cortical 
(Ressler and Mayberg, 2007).
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The carotid body is an organ of the peripheral nervous system that senses oxygen concen-
tration in the blood and responds to changes by regulating breathing. Pardal et al. (2007) 
now report the discovery of carotid body stem cells, which proliferate in response to hypoxia 
and generate neurons that secrete dopamine. This new source of adult stem cells may be 
useful in therapies for treating Parkinson’s disease.When Edmund Hillary climbed with 
Tenzing Norgay into thin air in their 
campaign to conquer Everest, little 
did they know that an intriguing piece 
of stem cell biology was contributing 
to their success. In this issue, Pardal 
et al., (2007) reveal that in low-oxygen 
conditions, a glia-like stem cell popu-
lation of the carotid body proliferates 
and generates new dopaminergic 
neurons that contribute to an increase 
in ventilation. This is the first finding 
of in vivo neurogenesis from adult 
stem cells derived from the neural 
crest. Moreover, the demonstration 
that carotid stem cells can be grown 
in tissue culture opens up an excit-
ing possibility—to expand a patient’s 234 Cell 131, October 19, 2007 ©2007 Elown cells ex vivo for autologous cell 
therapy to treat Parkinson’s disease.
Neurogenesis is highly restricted 
in adulthood. In the adult central 
nervous system (CNS), neurons are 
formed in the dentate gyrus of the hip-
pocampus and in the subventricular 
zone surrounding the lateral ventricle. 
Adult CNS stem cells resemble astro-
cytes (a major type of glial cell) in their 
ultrastructural features and expres-
sion of glial fibrillary acidic protein 
(GFAP) (Alvarez-Buylla and Lim, 2004; 
Doetsch et al., 1999). In the peripheral 
nervous system (PNS), neurogenesis 
persists in the olfactory neuroepithe-
lium, which produces sensory neu-
rons throughout life for odor detec-sevier Inc.tion (Beites et al., 2005). The work by 
Pardal et al. reveals another location 
for endogenous neurogenesis—the 
chemoreceptor carotid body.
The ability to adapt to short- and 
long-term exposure to low-oxygen 
environments is crucial for mammalian 
survival, and the carotid body, nes-
tled at the bifurcation of the internal 
and external carotid arteries, is a key 
component of the adaptive response 
(Figure 1). The carotid body consists 
of two main cell types, the excitable 
dopaminergic glomus cells and the 
sustentacular cells that resemble glia 
of the CNS in their supportive role 
and GFAP expression. The glomus 
cells, present in highly vascularized 
clusters throughout the carotid body, 
are chemoreceptor cells exquisitely 
sensitive to changes in oxygen levels 
in arterial blood. Reduction in avail-
able oxygen activates the glomus 
cells, resulting in membrane depo-
larization and release of neurotrans-
mitters, including acetylcholine, ATP, 
and dopamine. These factors bind to 
sensory fibers that carry a message 
to the brainstem respiratory center to 
stimulate ventilation, thereby increas-
ing the availability of oxygen.
One intriguing feature of the carotid 
body is that in addition to its immedi-
ate response to acute hypoxia, chronic 
hypoxia (such as acclimation to high 
altitudes) results in a dramatic increase 
in its size. Pardal and colleagues dis-
covered that the increase in size is 
due to neurogenesis resulting from 
the proliferation and differentiation of 
stem cells. Using bromodeoxyuridine 
(BrdU), a label of proliferative cells, they 
observed a dramatic increase in cell 
division in rats exposed to a hypoxic 
environment. After 5 days of hypoxia, 
many BrdU+ cells also expressed 
tyrosine hydroxylase (TH), a marker of 
dopaminergic neurons. Upon restora-
tion of normoxia, the carotid body dis-
plays remarkable plasticity, returning 
to its normal size with nearly half of the 
glomus cells being newly generated.
The authors then showed that 
cells extracted from the carotid 
body and cultured under hypoxic 
conditions express the progeni-
tor marker Nestin and proliferate 
to form multicell spheres, a hall-
mark of neural stem cell activity. A 
small percentage of these cells self 
renew, even under these stringent 
conditions outside the normal niche. 
The authors tracked sphere growth 
over time and watched a surprising 
transformation take place. After a 
few days, they produced a grow-
ing bud of TH+ cells that eventu-
ally formed a paired-sphere struc-
ture with progenitors on one lobe 
and differentiated progeny on the 
other. Importantly, these TH+ cells 
generated in vitro had essentially 
the same responses as normal glo-
mus cells: hypoxia caused them to 
become depolarized and to secrete 
dopamine.figure 1. neurogenesis in the carotid Body and the subventricular Zone
(A) The carotid body of the peripheral nervous system is located at the bifurcation of the carotid 
artery. Under normoxic conditions, clusters of dopaminergic glomus cells (green) are associated 
with glia-like sustentacular cells that express glial fibrillary acidic protein (GFAP+) (yellow) and a 
few Nestin+ cells (blue). Afferents to the central nervous system (CNS) are represented in blue and 
blood vessels in red. Under hypoxic conditions, GFAP+ sustentacular cells proliferate and convert 
into GFAP−/Nestin+ transit-amplifying cells that give rise to new tyrosine hydroxylase-positive 
dopaminergic cells. Note that following a return to normoxic conditions, Nestin+ transit-amplifying 
cells convert back to GFAP+ resting sustentacular cells.
(B) In the adult subventricular zone (SVZ), GFAP+ stem cells (yellow) give rise to GFAP− transit am-
plifying cells (blue) that ultimately give rise to migratory neuroblasts (green). The transit-amplifying 
cells express dlx2 and high levels of the epidermal growth factor receptor (EGFR).Which cell type is responsible 
for growth of the carotid body? The 
observation that almost all GFAP 
immunoreactivity disappeared fol-
lowing hypoxia and then reappeared 
under normoxic conditions suggested 
the glia-like sustentacular cells could 
be responsible, an idea confirmed 
using transgenic mice that express 
lacZ in cells with a history of GFAP 
expression. Further characterization 
revealed that GFAP+ sustentacular 
cells activated by hypoxia give rise to 
proliferating Nestin+ GFAP− progenitor 
cells that in turn produce dopamin-
ergic glomus cells, a lineage resem-
bling that of CNS stem cells (Figure 
1). Importantly, upon returning to nor-
moxia, the carotid growth regresses 
and the activated stem cells return to 
their normal GFAP+ sustentacular cell 
state. Understanding the mechanism 
of this reversal could tell us about the 
relationship between the quiescent 
and activated states, an issue rel-
evant to other classes of stem cells 
including tumor stem cells.Cell 131, OUsing a Wnt1 reporter, the authors 
showed that the carotid body stem 
cell is derived from the neural crest. 
Prior reports of neurons generated 
from adult neural crest stem cells, in 
the skin and enteric nervous systems, 
have been limited to in vitro studies 
(Fernandes et al., 2007; Kruger et al., 
2002). Now that we recognize that neu-
rogenesis of the carotid body requires 
hypoxia, we speculate that specific 
injury or stress could induce endog-
enous neurogenesis from other neural 
crest stem cells. However, we still need 
to uncover the mechanism of stem cell 
activation. Is low availability of oxygen 
first detected by glomus cells that then 
signal to the sustentacular cells to acti-
vate their stem cell activity, or do the 
sustentacular cells respond directly 
to hypoxia? This latter possibility is 
plausible given in vitro studies show-
ing that when cultured under hypoxic 
conditions, neural crest and other neu-
ral stem cells display enhanced prolif-
eration and generate a higher number 
of TH+ cells (Pistollato et al., 2007 and ctober 19, 2007 ©2007 Elsevier Inc. 235
references therein). We also should not 
ignore the possibility of other endog-
enous signals that come from the 
vasculature to the stem cells. Given 
the importance of the vascular niche 
to a variety of stem cells, understand-
ing the signaling pathway for stem cell 
activation in the carotid body could 
have broader implications.
Perhaps the most exciting aspect 
of the discovery of carotid body 
stem cells is their potential for clini-
cal application. Parkinson’s disease 
is a debilitating neurological disorder 
characterized by loss of dopaminer-
gic neurons of the substantia nigra 
that project to the striatum. Intrastri-
atal grafting of dopamine-producing 
cells is an attractive therapeutic strat-
egy. Glomus cells are a promising 
cell source, because they are readily 
obtained from the carotid body of the 
patient, thus obviating the need for 
immunosuppressive therapies that 
would accompany the transplanta-
tion of nonautologous donor cells. 
Furthermore, these cells thrive in low-
oxygen tension, conditions typical 
of brain parenchyma. Lopez-Barneo 236 Cell 131, October 19, 2007 ©2007 E
Actin filaments contribute to almost 
all types of cellular movement. They 
are involved in wound repair, orches-
trating morphogenesis, establish-
ing neuronal circuits, and defending 
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nervous system during develoand colleagues showed that trans-
plantation of carotid body cell aggre-
gates significantly ameliorates motor 
deficiency in a rat model of Parkin-
son’s disease (Espejo et al., 1998), 
and recent clinical trials using cell 
aggregates derived from the carotid 
body have reported encouraging 
results in Parkinson’s patients (Min-
guez-Castellanos et al., 2007). How-
ever, a limitation is the small number 
of cells that can be extracted from 
the carotid body. The identification of 
carotid body stem cells may make it 
possible to generate sufficient cells 
ex vivo for transplantation and allow 
for genetic manipulation of the cells 
if necessary.
Although adult stem cells have 
been vilified by some, largely due to 
misrepresentation of their plasticity 
by crusaders against embryonic stem 
cells, the findings by Pardal et al. and 
others point to their promise. Now is 
the time to embrace the entire breadth 
of stem cell biology and to celebrate 
the discovery of new stem cell niches 
and the growing possibilities of stem 
cell-related therapies.lsevier Inc.
against invading pathogens. Actin 
generates force and builds cellular 
structures through the assembly, 
disassembly, and organization of net-
works of filaments. The rate-limiting 
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